Trident Texofab Q2 FY27 Results: Net Profit ₹0.6 Cr, Down 45.5% YoY
Trident Texofab approved unaudited standalone results for the quarter ended September 2026. Quarterly revenue fell to ₹2,533.77 lakh from ₹3,063.46 lakh a year earlier.
- Key figure
- Net profit ₹0.6 Cr · -45.5% YoY